Repare Therapeutics Funding: $151M Raised, Series B (2019)
Repare Therapeutics is based in Montreal, Canada. It has raised $151M in total funding. Latest round: Series B.
Repare Therapeutics funding overview
Repare Therapeutics is based in Montreal, Canada. Repare Therapeutics has raised $151M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2019. The round record for Repare Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Cowen Healthcare Investments, OrbiMed, Redmile, BVF Partners, Logos Capital, Versant and 2 others. 8 distinct backers are named across the disclosed rounds.
Frequently asked about Repare Therapeutics funding
How much has Repare Therapeutics raised?
Repare Therapeutics has raised $151M in total disclosed funding across the rounds on record.
Who has invested in Repare Therapeutics?
Cowen Healthcare Investments, OrbiMed, Redmile, BVF Partners, Logos Capital, Versant are named among the investors backing Repare Therapeutics.
What was the latest Repare Therapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2019.
Where is Repare Therapeutics based?
Repare Therapeutics is based in Montreal, Canada.
When did Repare Therapeutics last raise?
The last disclosed Repare Therapeutics round closed in September 2019 at Series B.
Every Repare Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Montreal at a similar stage.
